The 9 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 10.00, with a high estimate of 13.00 and a low estimate of 8.00. The median estimate represents a 0.00% increase from the last price of 10.00.
The current consensus among 14 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.62
Reporting Date Nov 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.